Selective Serotonin Reuptake Inhibitors Modify Physiological Gastrointestinal Motor Activities via 5-HT2c Receptor and Acyl Ghrelin

Biological Psychiatry

Volumn 65, Issue 9, 2009, Pages 748-759

  Fujitsuka, Naoki ^a,b   Asakawa, Akihiro ^a   Hayashi, Mizuki ^a,b   Sameshima, Marie ^a   Amitani, Haruka ^a   Kojima, Shinya ^a   Fujimiya, Mineko ^c   Inui, Akio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Tsumura Laboratory   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT2c; gastrointestinal motility; ghrelin; melanocortin; SSRIs

Indexed keywords

ACYL GHRELIN; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; GHRELIN; MELANOCORTIN 4 RECEPTOR; PAROXETINE; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DUODENUM; GASTROINTESTINAL MOTILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; STOMACH ANTRUM; STOMACH MUSCLE;

ANIMALS; DRUGS, CHINESE HERBAL; EATING; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; GASTROINTESTINAL MOTILITY; GHRELIN; GROWTH HORMONE; INJECTIONS, INTRAVENTRICULAR; MALE; OLIGOPEPTIDES; PAROXETINE; PIPERAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, GHRELIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 63449106102     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.10.031     Document Type: Article

References (52)

1. Halford J.C., Harrold J.A., Boyland E.J., Lawton C.L., and Blundell J.E. Serotonergic drugs: Effects on appetite expression and use for the treatment of obesity. Drugs 67 (2007) 27-55
2. Kiev A., and Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry 58 (1997) 146-152
3. Brambilla P., Cipriani A., Hotopf M., and Barbui C. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: A meta-analysis of clinical trial data. Pharmacopsychiatry 38 (2005) 69-77
4. Ueda N., Yoshimura R., Shinkai K., Sakata Y., and Nakamura J. Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea. Neuropsychobiology 48 (2003) 31-34
5. Inui A. Cancer anorexia-cachexia syndrome: Current issues in research and management. CA Cancer J Clin 52 (2002) 72-91
6. North C.S., Hong B.A., and Alpers D.H. Relationship of functional gastrointestinal disorders and psychiatric disorders: Implications for treatment. World J Gastroenterol 13 (2007) 2020-2027
7. Levy R.L., Olden K.W., Naliboff B.D., Bradley L.A., Francisconi C., Drossman D.A., et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 130 (2006) 1447-1458
8. Galligan J.J., and Parkman H. Recent advances in understanding the role of serotonin in gastrointestinal motility and functional bowel disorders. Neurogastroentero Motil 19 (2007) 1-4
9. Fujimiya M., Itoh E., Kihara N., Yamamoto I., Fujimura M., and Inui A. Neuropeptide Y induces fasted pattern of duodenal motility via Y(2) receptors in conscious fed rats. Am J Physiol Gastrointest Liver Physiol 278 (2000) G32-G38
10. Fujino K., Inui A., Asakawa A., Kihara N., Fujimura M., and Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 550 (2003) 227-240
11. Kihara N., Fujimura M., Yamamoto I., Itoh E., Inui A., and Fujimiya M. Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. Am J Physiol Gastrointest Liver Physiol 280 (2001) G406-G419
12. Rodríguez-Membrilla A., and Vergara P. Endogenous CCK disrupts the MMC pattern via capsaicin-sensitive vagal afferent fibers in the rat. Am J Physiol 272 (1997) G100-G105
13. Preskorn S.H. Outpatient Management of Depression (1999), Professional Communications, New York 58-101
14. Heisler L.K., Jobst E.E., Sutton G.M., Zhou L., Borok E., Thornton-Jones Z., et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51 (2006) 239-249 2006
15. Clifton P.G., Lee M.D., and Dourish C.T. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat. Psychopharmacology (Berl) 152 (2000) 256-267
16. Lam D.D., Przydzial M.J., Ridley S.H., Yeo G.S., Rochford J.J., O'Rahilly S., and Heisler L.K. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149 (2008) 1323-1328
17. Heisler L.K., Cowley M.A., Tecott L.H., Fan W., Low M.J., Smart J.L., et al. Activation of central melanocortin pathways by fenfluramine. Science 297 (2002) 609-611
18. Hosoda H., and Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul Pept 146 (2008) 12-18
19. Takeda H., Sadakane C., Hattori T., Katsurada T., Ohkawara T., Nagai K., et al. Rikkunshito, a herbal medicine, suppresses cisplatin-induced anorexia in rats via serotonin 2 receptor antagonism. Gastroenterology 134 (2008) 2004-2013
20. Ariga H., Tsukamoto K., Chen C., Mantyh C., Pappas T.N., and Takahashi T. Endogenous acyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach. Neurogastroenterol Motil 19 (2007) 675-680
21. Depoortere I., Thijs T., and Peeters T. The contractile effect of the ghrelin receptor antagonist, D-Lys3-GHRP-6, in rat fundic strips is mediated through 5-HT receptors. Eur J Pharmacol 537 (2006) 160-165
22. Peeters T.L. Ghrelin: A new player in the control of gastrointestinal functions. Gut 54 (2005) 1638-1649
23. Vickers S.P., Easton N., Webster L.J., Wyatt A., Bickerdike M.J., Dourish C.T., et al. Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology 167 (2003) 274-280
24. Vickers S.P., Dourish C.T., and Kennett G.A. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology 41 (2001) 200-209
25. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374 (1995) 542-546
26. Nonogaki K., Abdallah L., Goulding E.H., Bonasera S.J., and Tecott L.H. Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT2C receptor mutant mice. Diabetes 52 (2003) 315-320
27. Vickers S.P., Clifton P.G., Dourish C.T., and Tecott L.H. Reduced satiating effect of d-fenfluramine in serotonin 5-HT2c receptor mutant mice. Psychopharmacology 143 (1999) 309-314
28. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., and Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351 (1995) 357-373
29. Kamiji M.M., and Inui A. Neuropeptide Y receptor selective ligands in the treatment of obesity. Endocr Rev 28 (2007) 664-684
30. Inui A. Transgenic approach to the study of body weight regulation. Pharmacol Rev 52 (2000) 35-61
31. Inui A. Ghrelin: An orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2 (2001) 551-560
32. Camilleri M., and Grudell A.B. Appetite and obesity: A gastroenterologist's perspective. Neurogastroenterol Motil 19 (2007) 333-341
33. Berthoud H.R. Vagal and hormonal gut brain communication: From satiation to satisfaction. Neurogastroenterol Motil 20 (2008) 64-72
34. Wren A.M., and Bloom S.R. Gut hormones and appetite control. Gastroenterology 132 (2007) 2116-2130
35. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
36. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 (2001) 337-345
37. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145 (2004) 2607-2612
38. Cummings D.E. Ghrelin and the short-and long-term regulation of appetite and body weight. Physiol Behav 89 (2006) 71-84
39. Farooqi S., and O'Rahilly S. Genetics of obesity in humans. Endocr Rev 27 (2006) 710-718
40. Dryden S., Wang Q., Frankish H.M., and Williams G. Differential effects of the 5-HT 1B/2C receptor agonist mCPP and the 5-HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: Evidence that NPY may mediate serotonin's effects on food intake. Peptides 17 (1996) 943-949
41. Balthasar N., Dalgaard L.T., Lee C.E., Yu J., Funahashi H., Williams T., et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123 (2005) 493-505
42. Nonogaki K., Ohashi-Nozue K., and Oka Y. A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. Biochem Biophys Res Commun 341 (2006) 703-707
43. Bailey J.E., Potoar J., Coupland N., and Nutt D.J. The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man. J Psychopharmacol 9 (1995) 137-141
44. Trifunovic R., and Reilly S. Medial parabrachial nucleus neurons modulate d-fenfluramine-induced anorexia through 5HT2C receptors. Brain Res 1067 (2006) 170-176
45. Li B.H., and Rowland N.E. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res Bull 31 (1993) 43-48
46. Li B.H., Xu B., Rowland N.E., and Kalra S.P. c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption. Brain Res 665 (1994) 277-284
47. Kido T., Nakai Y., Kase Y., Sakakibara I., Nomura M., Takeda S., et al. Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine. J Pharmacol Sci 98 (2005) 161-167
48. Goso Y., Ogata Y., Ishihara K., and Hotta K. Effects of traditional herbal medicine on gastric mucin against ethanol-induced gastric injury in rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 113 (1996) 17-21
49. Grundy D., Al-Chaer E.D., Aziz Q., Collins S.M., Ke M., Tache Y., et al. Fundamentals of neurogastroenterology: Basic science. Gastroenterology 130 (2006) 1391-1411
50. Gershon M.D., and Tack J. The serotonin signaling system: From basic understanding to drug development for functional GI disorders. Gastroenterology 132 (2007) 397-414
51. Zhou L., Sutton G.M., Rochford J.J., Semple R.K., Lam D.D., Oksanen L.J., et al. Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metabolism 6 (2007) 398-405
52. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 117 (2007) 3475-3488